Thetford Mines, Quebec – September 9, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to provide an update on its technological platforms in the cannabis field for medical purposes (the “Elixir420”) previously announced in its press release dated April 9, 2020.